- Report
- February 2026
- 250 Pages
Global
From €4127EUR$4,490USD£3,509GBP
- Report
- February 2026
- 250 Pages
Global
From €4127EUR$4,490USD£3,509GBP
- Report
- January 2026
- 180 Pages
Global
From €4137EUR$4,500USD£3,517GBP
- Drug Pipelines
- September 2026
- 150 Pages
Global
From €3447EUR$3,750USD£2,931GBP
- Report
- September 2026
- 200 Pages
Global
From €7345EUR$7,990USD£6,245GBP
- Report
- July 2026
- 200 Pages
Global
From €7345EUR$7,990USD£6,245GBP
- Report
- May 2026
- 140 Pages
Global
From €4366EUR$4,750USD£3,712GBP
- Report
- July 2026
- 160 Pages
Global
From €4366EUR$4,750USD£3,712GBP
- Report
- August 2026
- 70 Pages
Europe
From €4366EUR$4,750USD£3,712GBP
- Report
- August 2020
- 250 Pages
Saudi Arabia
From €3309EUR$3,600USD£2,814GBP
- Report
- February 2023
- 130 Pages
France
From €2289EUR$2,490USD£1,946GBP
- Report
- August 2025
- 150 Pages
Global
From €5469EUR$5,950USD£4,650GBP
- Report
- September 2024
- 110 Pages
Global
From €5469EUR$5,950USD£4,650GBP
- Report
- January 2024
- 200 Pages
Global
From €3815EUR$4,150USD£3,243GBP
- Report
- August 2025
- 185 Pages
Global
From €4137EUR$4,500USD£3,517GBP
- Report
- April 2024
- 30 Pages
Global
From €2988EUR$3,250USD£2,540GBP
- Report
- January 2024
- 189 Pages
Global
From €6894EUR$7,500USD£5,862GBP
- Report
- August 2026
- 120 Pages
Mexico
From €4366EUR$4,750USD£3,712GBP
- Report
- July 2024
- 70 Pages
Brazil
From €4366EUR$4,750USD£3,712GBP
- Report
- February 2024
- 150 Pages
Global
From €4366EUR$4,750USD£3,712GBP

Jardiance is a medication used to treat type 2 diabetes, a condition in which the body does not produce enough insulin or does not use insulin properly. It belongs to a class of drugs known as sodium-glucose cotransporter-2 (SGLT2) inhibitors, which work by blocking the reabsorption of glucose in the kidneys, allowing it to be excreted in the urine. This helps to lower blood sugar levels. Jardiance is typically used in combination with other diabetes medications, such as metformin, to help control blood sugar levels.
Jardiance is part of a larger market of endocrine and metabolic disorder drugs, which includes medications used to treat conditions such as obesity, thyroid disorders, and polycystic ovary syndrome. These drugs are used to help regulate hormones and metabolism, and can help to improve overall health and quality of life.
Companies in the Jardiance market include Boehringer Ingelheim, Merck, and Eli Lilly. Show Less Read more